Gleiss Lutz advised Aspirant Group on the transaction.
Aspirant Group, a Japanese private equity investor, announced the acquisition of a stake in DIPSOL Chemical Co., Ltd.
The Japanese company DIPSOL was founded in 1953 with the name Toei Chemicals and then renamed DIPSOL Chemical in 1968. DIPSOL is a leading global specialist in the development and production of surface treatment technologies to improve the durability and functionality of metal surfaces. The company has 17 branches in 12 countries, including in Düsseldorf. In its home market, Japan, DIPSOL is a market leader for functional zinc and zinc alloy systems and thus an important supplier for automobile manufacturers and tier 1 suppliers.
Aspirant Group is engaged in the private equity business and supports companies in terms of their strategic development in order to promote sustainable and long-term growth.
The Gleiss Lutz team was led by Dr. Michael Burian (Picture) and included Dr. Christopher Vogl and Jannik Hermes.
Law Firms: Gleiss Lutz;
Clients: Aspirant Group;